R

ReNeuron Group PLC
LSE:RENE

Watchlist Manager
ReNeuron Group PLC
LSE:RENE
Watchlist
Price: 3.375 GBX -2.17%
Market Cap: 1.9m GBX

Wall Street
Price Targets

RENE Price Targets Summary
ReNeuron Group PLC

There are no price targets for RENE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
ReNeuron Group PLC Competitors:
Price Targets
RCUS
Arcus Biosciences Inc
44% Upside
ATX
Amplia Therapeutics Ltd
186% Upside
HALO
Halozyme Therapeutics Inc
10% Upside
2157
Lepu Biopharma Co Ltd
88% Upside
PHIL
Philogen SpA
23% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
49% Upside
FHTX
Foghorn Therapeutics Inc.
80% Upside
CMPX
Compass Therapeutics Inc.
118% Upside

Revenue
Forecast

Revenue Estimate
ReNeuron Group PLC

For the last 8 years the compound annual growth rate for ReNeuron Group PLC's revenue is 43%. The projected CAGR for the next 2 years is 380%.

43%
Past Growth
380%
Estimated Growth
Estimates Accuracy
-62%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ReNeuron Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
ReNeuron Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RENE's stock price target?
Not Available

RENE doesn't have any price targets made by Wall Street professionals.

What is ReNeuron Group PLC's Revenue forecast?
Projected CAGR
380%

For the last 8 years the compound annual growth rate for ReNeuron Group PLC's revenue is 43%. The projected CAGR for the next 2 years is 380%.

Back to Top